Although the clinical benefit of laparoscopic splenectomy and devascularization（LSD） has been elaborated in many studies,its application in massive splenomegaly remains controversial.We conducted a retrospective res...Although the clinical benefit of laparoscopic splenectomy and devascularization（LSD） has been elaborated in many studies,its application in massive splenomegaly remains controversial.We conducted a retrospective research to assess the curative efficacy of LSD for massive splenomegaly due to portal hypertension.Forty-seven patients with massive splenomegaly due to portal hypertension were enrolled in this study,and divided into two groups.Twenty-one patients underwent open splenectomy and devascularization（OSD） from June 2010 to October 2012（OSD group）.From March 2013 to February 2015,LSD was performed on 26 patients（LSD group）.Perioperative variables were analyzed.Compared to OSD,LSD was associated with less blood loss（241.9±110.0 m L vs.319.0±139.5 m L,P〈0.05）,more rapid resumption of oral diet（2.46±0.95 days vs.3.76±1.09 days,P〈0.05）,and shorter postoperative hospital stay（5.35±1.65 days vs.7.24±1.55 days,P〈0.05）.It was concluded that for patients with massive splenomegaly due to portal hypertension,LSD is feasible and as safe as OSD.展开更多
目的探讨腹腔镜巨脾切除的适应证与手术疗效。方法对23例腹腔镜巨脾切除病例与53例腹腔镜普通大小脾脏切除及35例开腹巨脾切除病例的手术疗效进行比较。结果本组腹腔镜巨脾切除23例,其中3例同时行腹腔镜巨脾切除伴贲门周围血管离断术,9...目的探讨腹腔镜巨脾切除的适应证与手术疗效。方法对23例腹腔镜巨脾切除病例与53例腹腔镜普通大小脾脏切除及35例开腹巨脾切除病例的手术疗效进行比较。结果本组腹腔镜巨脾切除23例,其中3例同时行腹腔镜巨脾切除伴贲门周围血管离断术,9例同时行胆囊切除术,无手术死亡,其中2例中转开腹。巨脾组和普通组相比,手术时间长[(142±29)min vs (92±18)min]和术中出血量多[(540±90)ml vs (210±80)ml](P均<0.05),术后住院时间、腹腔引流置管时间、术后并发症和中转开腹率方面没有差异。巨脾组与开腹组相比,术后腹腔镜引流置管时间[(4.7±0.5)dvs(7.7±0.9)d]和术后住院时间[(5.7±0.5)d vs (8.4±0.9)d]短,术后并发症少(4.3% vs 11.4%)(P均<0.05),但术中出血和手术时间差异没有统计学意义。结论腹腔镜巨脾切除术安全可行,近期疗效良好。展开更多
目的总结全腹腔镜下二级脾蒂离断法原位巨脾切除术的手术要点和临床体会。方法回顾性分析2013年1月~2017年6月48例实施巨脾切除术的患者临床资料,根据手术方式分为观察组(全腹腔镜下二级脾蒂离断法原位巨脾切除)和开放组(开腹传统法)。...目的总结全腹腔镜下二级脾蒂离断法原位巨脾切除术的手术要点和临床体会。方法回顾性分析2013年1月~2017年6月48例实施巨脾切除术的患者临床资料,根据手术方式分为观察组(全腹腔镜下二级脾蒂离断法原位巨脾切除)和开放组(开腹传统法)。比较2组患者手术时间、术中出血、留置腹腔引流管情况、术后拔除引流管时间、并发症及术后住院时间等指标。结果48例患者均成功完成手术,其中观察组25例均成功在全腹腔镜下完成二级脾蒂离断法原位脾切除术,无中转开腹,观察组手术时间比开放组长(130.40±63.60 min vs 99.13±33.97 min,P=0.038),术中出血量更少(75.20±50.67 mL vs 206.09±116.77 mL,P=0.000),术后住院时间更短(8.24±2.20天vs 11.00±3.49天,P=0.002);观察组留置腹腔引流管的例数更少,差异有统计学意义(P<0.05),但两组术后拔除引流管的时间相当;两组间脾窝积液、切口感染和发热两组差异无统计学意义(P>0.05);而观察组术后胸腔积液少于开放组,其差异有统计学意义(P<0.05));两组均无腹腔出血,腹腔感染,门静脉系统血栓,胰瘘,胃瘘,肝功能衰竭等并发症。术后随访6个月,患者无门静脉系统血栓及肝功能衰竭并发症,胸腔积液已吸收。结论全腹腔镜下二级脾蒂离断法原位巨脾切除安全可靠,与开腹传统方法比较,术中出血更少,恢复更快。展开更多
文摘Although the clinical benefit of laparoscopic splenectomy and devascularization（LSD） has been elaborated in many studies,its application in massive splenomegaly remains controversial.We conducted a retrospective research to assess the curative efficacy of LSD for massive splenomegaly due to portal hypertension.Forty-seven patients with massive splenomegaly due to portal hypertension were enrolled in this study,and divided into two groups.Twenty-one patients underwent open splenectomy and devascularization（OSD） from June 2010 to October 2012（OSD group）.From March 2013 to February 2015,LSD was performed on 26 patients（LSD group）.Perioperative variables were analyzed.Compared to OSD,LSD was associated with less blood loss（241.9±110.0 m L vs.319.0±139.5 m L,P〈0.05）,more rapid resumption of oral diet（2.46±0.95 days vs.3.76±1.09 days,P〈0.05）,and shorter postoperative hospital stay（5.35±1.65 days vs.7.24±1.55 days,P〈0.05）.It was concluded that for patients with massive splenomegaly due to portal hypertension,LSD is feasible and as safe as OSD.
文摘目的探讨腹腔镜巨脾切除的适应证与手术疗效。方法对23例腹腔镜巨脾切除病例与53例腹腔镜普通大小脾脏切除及35例开腹巨脾切除病例的手术疗效进行比较。结果本组腹腔镜巨脾切除23例,其中3例同时行腹腔镜巨脾切除伴贲门周围血管离断术,9例同时行胆囊切除术,无手术死亡,其中2例中转开腹。巨脾组和普通组相比,手术时间长[(142±29)min vs (92±18)min]和术中出血量多[(540±90)ml vs (210±80)ml](P均<0.05),术后住院时间、腹腔引流置管时间、术后并发症和中转开腹率方面没有差异。巨脾组与开腹组相比,术后腹腔镜引流置管时间[(4.7±0.5)dvs(7.7±0.9)d]和术后住院时间[(5.7±0.5)d vs (8.4±0.9)d]短,术后并发症少(4.3% vs 11.4%)(P均<0.05),但术中出血和手术时间差异没有统计学意义。结论腹腔镜巨脾切除术安全可行,近期疗效良好。
文摘目的总结全腹腔镜下二级脾蒂离断法原位巨脾切除术的手术要点和临床体会。方法回顾性分析2013年1月~2017年6月48例实施巨脾切除术的患者临床资料,根据手术方式分为观察组(全腹腔镜下二级脾蒂离断法原位巨脾切除)和开放组(开腹传统法)。比较2组患者手术时间、术中出血、留置腹腔引流管情况、术后拔除引流管时间、并发症及术后住院时间等指标。结果48例患者均成功完成手术,其中观察组25例均成功在全腹腔镜下完成二级脾蒂离断法原位脾切除术,无中转开腹,观察组手术时间比开放组长(130.40±63.60 min vs 99.13±33.97 min,P=0.038),术中出血量更少(75.20±50.67 mL vs 206.09±116.77 mL,P=0.000),术后住院时间更短(8.24±2.20天vs 11.00±3.49天,P=0.002);观察组留置腹腔引流管的例数更少,差异有统计学意义(P<0.05),但两组术后拔除引流管的时间相当;两组间脾窝积液、切口感染和发热两组差异无统计学意义(P>0.05);而观察组术后胸腔积液少于开放组,其差异有统计学意义(P<0.05));两组均无腹腔出血,腹腔感染,门静脉系统血栓,胰瘘,胃瘘,肝功能衰竭等并发症。术后随访6个月,患者无门静脉系统血栓及肝功能衰竭并发症,胸腔积液已吸收。结论全腹腔镜下二级脾蒂离断法原位巨脾切除安全可靠,与开腹传统方法比较,术中出血更少,恢复更快。
